SOLNIXON DIN 02550474
Status: Marketed
Holder: BIMEDA-MTC ANIMAL HEALTH INC
Molecule: FLUNIXIN (FLUNIXIN MEGLUMINE)
Available to quote
Health Canada record
| Active ingredient(s) | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 15-May-2025 |
| Current status date | 15-May-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bimeda-MTC Animal Health Inc. — licence 100306, currently licensed, last inspection rating NC (2026-03-02).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUNIXIN (FLUNIXIN MEGLUMINE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02457180 | BANAMINE | INTERVET CANADA CORP | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 00465305 | BANAMINE | INTERVET CANADA CORP | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02240510 | FLUNAZINE | BIMEDA-MTC ANIMAL HEALTH INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02563584 | FLUTREXIN | MODERN VETERINARY THERAPEUTICS LLC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02234061 | SOLVEZINE | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 00465291 | BANAMINE GRANULES | SCHERING-PLOUGH CANADA INC | Granules | FLUNIXIN (FLUNIXIN MEGLUMINE) 25 MG | Cancelled Post Market |
| 02231381 | CITATION INJECTION | BAYER INC., ANIMAL HEALTH | Liquid | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02230652 | CRONYXIN INJECTION | CROSS VETPHARM GROUP LTD | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02239149 | INFLUX-50 (FLUNIXIN MEGLUMINE INJECTION) STERILE INJECTABLE SOLUTION | VETOQUINOL N A INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02248807 | SUPPRESSOR | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02478951 | VETONIXIN | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 33786 | 2024-08-09 | Abbreviated New Drug Submission (ANDS) | Administrative - Additional Product Name |